@article{851233,
      recid = {851233},
      author = {Carreyrou, John,},
      title = {Bad blood : secrets and lies in a Silicon Valley startup  /},
      pages = {x, 339 pages ;},
      abstract = {"In 2014, Theranos founder and CEO Elizabeth Holmes was  widely seen as the female Steve Jobs: a brilliant Stanford  dropout whose startup "unicorn" promised to revolutionize  the medical industry with a machine that would make blood  tests significantly faster and easier. Backed by investors  such as Larry Ellison and Tim Draper, Theranos sold shares  in a fundraising round that valued the company at $9  billion, putting Holmes's worth at an estimated $4.7  billion. There was just one problem: The technology didn't  work. For years, Holmes had been misleading investors, FDA  officials, and her own employees. When John Carreyrou,  working at The Wall Street Journal, got a tip from a former  Theranos employee and started asking questions, both  Carreyrou and the Journal were threatened with lawsuits.  Undaunted, the newspaper ran the first of dozens of  Theranos articles in late 2015. By early 2017, the  company's value was zero and Holmes faced potential legal  action from the government and her investors. The biggest  corporate fraud since Enron is a cautionary tale set amid  the bold promises and gold-rush frenzy of Silicon Valley."  -- Publisher's description},
      url = {http://library.usi.edu/record/851233},
}